Heike
Heike Barlag, Nurnberg DE
Patent application number | Description | Published |
---|---|---|
20090130658 | Arrangement for integrated and automated dna or protein analysis in a single-use cartridge, method for producing such a cartridge and operating method for dna or protein analysis using such a cartridge - A cartridge (card) having a system of microchannels and/or microcavities is used for automated DNA or protein analysis. In at least one embodiment, the microchannels or microcavities include geometrical structures for receiving dry reagents. For the purpose of industrial production, the cartridge is produced from a flat card support, e.g., by injection moulding. The reagents are spotted into the open channels, dried and then the channels are sealed by way of a film. A finished cartridge can thus be provided with a test sample and the fully automated measuring sequence can be initiated by inserting said cartridge into a read-out device. | 05-21-2009 |
20100155263 | METHOD AND SYTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE/ENZUME COMPLEX OR OF AN ANALYTE/ENZYME CONJUGATE, ESPECIALLY FOR THE ELECTROCHEMICAL DETECTION OF THE ANALYTE, AND CORRESPONDING MEASURING DEVICE - A method follow the change in concentration of a redox-active substance, whereby suitable potentials for a reduction process or an oxidation process are applied to the working electrode of a measuring device. The potential of the working electrode is pulsed and measuring phases and relaxation phases are alternately produced, the pulse lengths of measuring phase and relaxation phase being determined in a suitable manner. A rapid relaxation of the concentration gradient is electrochemically forced so that the measurement can be carried out on simple transducer arrays. A device for carrying out the method includes a transducer array in addition to a suitable potentiostat. The transducer array can be formed of a planar metal substrate on which at least one flexible insulator is disposed, the metal surface and the insulator surface being firmly linked. The transducer array can also be formed of silicone-based CMOS structures. | 06-24-2010 |
20130249484 | Method for Charging at Least One Energy Store of an Electric Vehicle - A method is disclosed for charging at least one energy store of an electric vehicle via a charging point, using a first terminal having first connecting elements of a charging cable connected to the charging point. The first connecting elements are connected to corresponding second connecting elements of a second terminal on the vehicle, and the first and second connecting elements are designed to supply alternating current for charging the at least one energy store. Direct current from the charging point for charging the at least one energy store is supplied to the electric vehicle via at least two first connecting elements or at least two third connecting elements of the first terminal, wherein PLC communication between the electric vehicle and charging point in order to exchange information relating to the charging operation occurs via one or more first connecting elements on which no direct current for charging is carried. | 09-26-2013 |
Heike Barlag, Nuremberg DE
Patent application number | Description | Published |
---|---|---|
20080283397 | Electrochemical Transducer Array and Use Thereof - Electrochemical transducer arrays are already known from the prior art. According to the invention, the transducer array is provided with at least one flexible, planar metal substrate on which at least one flexible insulator having a firm connection between the metal surface and the insulator surface is disposed. The metal substrate and the insulator disposed thereon are structured in such a manner as to give metal areas which are electrically insulated the one from the other and which serve as sensor areas. The metal substrate used is self-contained so that the structured metal areas can be contacted from the lower side. | 11-20-2008 |
20090136922 | Method for carrying out an electrochemical measurement on a liquid measuring sample in a measuring chamber that can be accessed by lines, and corresponding arrangement - Especially in order to carry out the so-called enzyme-coupled DNA hybridisation test in a closed cartridge including a microfluid system, using stored dry reagents, the reagents must be dissolved in the microfluid system and transported into the measuring chamber directly before the measurement. During the dissolution of the reagents in water, air cushions that cannot reach the measuring chamber must absolutely be prevented from forming upstream of the reagent liquid. According to an embodiment of the invention, the liquid measuring sample and the liquid reagents are transported in such a way that the air cushion is directed into the waste line and the measuring sample and the reagents are then introduced into the measuring chamber without any air bubbles. In this way, measuring errors can be avoided. | 05-28-2009 |
20130278273 | METHOD AND DEVICE FOR DETECTING SHORT CIRCUIT - In a charge cable which can be connected to an electric charging device to charge a battery of an electric vehicle, a method for detecting a short-circuit selects a first voltage value for a test voltage. By applying this test voltage to the charge cable, testing is carried out to determine whether there is a short-circuit , a fault signal is output; if there is a no short-circuit, the test voltage is increased incrementally up to a maximum voltage value. The increased test voltage is used to test whether there is a short-circuit in the charge cable or in the contact connected to the charge cable. | 10-24-2013 |
Heike Bartsch De Torres, Ilmenau DE
Patent application number | Description | Published |
---|---|---|
20100254099 | SILICON-CERAMIC COMPOSITE SUBSTRATE - The invention relates to a silicon-ceramic composite substrate ( | 10-07-2010 |
Heike Becker, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20080242577 | Clear Rinsing Agent Containing Hydrophobically Modified Polycarboxylates - Rinse agent formulations for machine dishwashing, comprising as components: | 10-02-2008 |
20080257190 | Use of Polymers Comprising Amino Groups Modified by Acid Groups for Producing Humidifying Agents or Humidifying Agent Concentrates, in Addition to Humidifying Agent Circuits for Offset Printing - The use of polymers which comprise amino groups modified with acid groups for the preparation of fountain solutions for offset printing. A process for printing by means of the offset technique, in which a fountain solution which comprises polymer which comprises amino groups modified with acid groups is used. | 10-23-2008 |
20090297884 | Use of hydrophobins for the surface treatment of hardened mineral building materials, natural stone, artificial stone and ceramics - Use of hydrophobins for treating the surface of cured mineral building materials, natural stone, cast stone or ceramic, a process for treating such surfaces and also surfaces of cured mineral building materials, natural stone, cast stone or ceramic that have a coating comprising hydrophobins. | 12-03-2009 |
20090305930 | Use of hydrophobin for hard surface soil-repellent treatment - Use of hydrophobins for soil-repellent treatment of hard surfaces, in particular in combination with a cleansing of the surface, processes for soil-repellent treatment of hard surfaces, cleansing agents for hard surfaces and also hard surfaces with a soil-repellent coating comprising hydrophobins. | 12-10-2009 |
20100004154 | THERMALLY SENSITIVE POLYMERIC DYE TRANSFER INHIBITOR - The invention relates to the use of thermally sensitive polymers as dye transfer inhibitors. The invention also relates to novel thermally sensitive polymers suitable as dye transfer inhibitors, and to washing compositions which comprise these polymers. | 01-07-2010 |
20100017973 | HYDROPHOBICALLY MODIFIED POLYALKYLENIMINES FOR USE AS DYE TRANSFER INHIBITORS - The invention relates to the use of hydrophobically modified polyalkylenimines as dye transfer inhibitors. | 01-28-2010 |
Heike Blasko-Begoihn, Essen DE
Patent application number | Description | Published |
---|---|---|
20110052522 | COSMETICS COMPRISING CISTUS PLANT EXTRACTS - The present invention relates to the use of an extract from | 03-03-2011 |
Heike Brücher, Rathsweiler DE
Patent application number | Description | Published |
---|---|---|
20110048509 | COMPOSITE EDGE FOR PRODUCING DOUBLE OR MULTIPLE PANE INSULATION GLASS OR SOLAR MODULES - This invention relates to an edge seal for manufacturing two-pane or multi-pane insulating glass or solar modules, there being provided a primary sealant and a secondary sealant. | 03-03-2011 |
20120192946 | USE OF CALCIUM OXIDE AS A WATER SCAVENGER IN SOLAR APPLICATIONS - A solar module includes an edge sealant. The sealant composition includes an unsaturated reactive polyolefin, an olefmic polymer, a silane modified polyolefin, inert fillers, calcium oxide, and aging resistors. These components are balanced to produce a sealant having desirable sealing characteristics, high weatherability, desired rheology, low conductivity, and good water absorption. | 08-02-2012 |
20120192947 | EDGE SEALANTS HAVING BALANCED PROPERTIES - A sealant composition for use in two-pane or multi-pane insulating glass or solar modules, the sealant composition including: a) an olefinic polymer having a number average molecular weight from about 100 D to about 700,000 D, preferably from about 100 D to about 300,000 D; b) a modified olefinic polymer; c) a fine-particle inert filler; d) at least one of a desiccant and a water scavenger, and e) an aging resistor. The sealant composition has a tensile strength greater than 20 PSI, preferably greater than 50 PSI, a lap shear strength greater than 20 PSI, preferable greater than 40 PSI, and the tensile and lap shear strengths balanced such that the sealant fails cohesively before failing adhesively. | 08-02-2012 |
20120199199 | EDGE SEALANT COMPOSITION WITH REACTIVE OR UNSATURATED POLYOLEFINS - A solar module includes a photovoltaic device that has an edge seal. The sealant composition of the edge seal includes an unsaturated or reactive polyolefin, an olefinic polymer, a silane modified polyolefin, inert fillers, a water scavenger or desiccant, an antioxidant, and a UV stabilizer. These components are balanced to produce a sealant having desirable sealing characteristics, high weatherability, desired rheology, low conductivity, and good thermal stability. | 08-09-2012 |
20120199200 | USE OF CARBON BLACK FOR OXIDATIVE AND HEAT STABILITY IN SOLAR MODULE APPLICATIONS - An edge seal for manufacturing two-pane or multi-pane insulating glass or solar modules includes a sealant and a bonding agent. The sealant contains a polymer modified with special reactive groups and has the following overall composition: olefinic polymers included in an amount from about 10% to about 90% by weight of the total composition; at least one filler included in an amount from about 10% to about 65% by weight of the total composition; at least one inorganic filler that is a thermal and oxidative stabilizer in an amount from about 2% to about 30%; at least one of a desiccant and a water scavenger included in an amount from about 2.5% to about 25% by weight of the total composition; and at least one aging resistor including an anti-oxidant or UV stabilizer included in an amount from about 0% to about 3% by weight of the total composition. | 08-09-2012 |
20130079446 | COMPOSITE EDGE FOR PRODUCING DOUBLE OR MULTIPLE PANE INSULATION GLASS OR SOLAR MODULES - An edge seal for manufacturing two-pane or multi-pane insulating glass or solar modules having a primary sealant and a secondary sealant has the following overall composition: | 03-28-2013 |
Heike Brüser, Speyer DE
Patent application number | Description | Published |
---|---|---|
20100310644 | ANTI-DANDRUFF COMPOSITIONS CONTAINING PEPTIDES - The present invention relates to the use of special peptides in composition which can be used in particular in hair and skin cosmetics, and to such peptide-containing compositions. In particular, the present invention relates to the use of such peptides as active ingredient for inhibition or treatment of dandruff which does not accumulate in the body or in the environment. Furthermore, the invention relates to the production of such compositions, to the peptides used themselves, to their production and to coding nucleotide sequences for such peptides, to dispensing systems for such peptides and to screening methods for identifying suitable further peptides. | 12-09-2010 |
Heike Dinter-Heidorn, Hannover DE
Patent application number | Description | Published |
---|---|---|
20090263479 | FORMULATIONS FOR POORLY PERMEABLE ACTIVE PHARMACEUTICAL INGREDIENTS - The present invention relates to a pharmaceutical oral dosage form containing a poorly permeable active pharmaceutical ingredient and at least one permeability improving substance, wherein the permeability improving substance is thermostably embedded in a water-soluble matrix of a water soluble carrier, and to thermostable formulations which can be used to improve bioavailability. | 10-22-2009 |
Heike Ebendorff-Heidepriem, Adelaide AU
Patent application number | Description | Published |
---|---|---|
20110045298 | FABRICATION OF NANOWIRES - A method of forming a nanowire is disclosed. In one embodiment, a primary preform is formed comprising at least one central region and a support structure. The primary preform is then drawn to a cane, which is then inserted into an outer portion, to form a secondary preform. The secondary preform is then drawn until the at least one central portion is a nanowire. The method can produce nanowires of far greater length than existing methods, and can reduce the likelihood of damaging the nanowire when handling. | 02-24-2011 |
Heike Ebendorff-Heidepriem, South Australia AU
Patent application number | Description | Published |
---|---|---|
20090028488 | FABRICATION OF NANOWIRES - A method of forming a nanowire is disclosed. In one embodiment, a primary preform is formed comprising at least one central region and a support structure. The primary preform is then drawn to a cane, which is then inserted into an outer portion, to form a secondary preform. The secondary preform is then drawn until the at least one central portion is a nanowire. The method can produce nanowires of far greater length than existing methods, and can reduce the likelihood of damaging the nanowire when handling. | 01-29-2009 |
20090220785 | METHOD AND DEVICE FOR FORMING MICROSTRUCTURED FIBRE - A die and method for extruding an extrudable material to form an extruded member is described. In one embodiment, the die comprises a barrier member comprising a plurality of feed channels that extend through the barrier member. Furthermore, the die incorporates a passage forming member extending from the barrier member substantially in the direction of extrusion. The feed channels are arranged with respect to the passage forming member to allow the extrudable material to substantially flow about the passage forming member to form a corresponding passage in the extruded member. | 09-03-2009 |
20100237255 | OPTICAL FIBER SENSOR - A sensor based on optical fiber technology is described. The sensor includes an elongate core for propagating light having an excitation wavelength; an interaction region that includes a fluorescent material for excitation by the propagated light to produce fluorescent light; and an interface region defining a boundary between the elongate core and the interaction region. The elongate core of the sensor is adapted to increase an intensity of the propagated light at the interface region to increase the amount of captured fluorescent light in the elongate core. | 09-23-2010 |
Heike Euting, Bocholt DE
Patent application number | Description | Published |
---|---|---|
20110092691 | Method For Filtering Nucleic Acids, In Particular From Fixed Tissue - The invention relates to a method for filtering nucleic acids, to a kit for carrying out the method according to the invention and to a novel use of magnetic particles for filtering a biological sample. The method according to the invention comprises the following steps: a) the sample is held in an aqueous solution; b) lysing of the sample; c) separation of cellular debris; and d) the nucleic acids are isolated from the solution, steps (a) to (c) taking place under non-chaotropic conditions. | 04-21-2011 |
20110245483 | Method For Purification Of Nucleic Acids, Particularly From Fixed Tissue - The invention relates to a method for purification of nucleic acids, to a kit for performing the method according to the invention and to a new application of magnetic particles for purification of a biological sample. The method according to the invention comprises the following steps: a) accommodating of the sample in a first sample vessel in an aqueous solution and lysing of the sample under non-chaotropic conditions; suspending of first magnetic particles in the solution and inserting of the first sample vessel in a sample vessel holder, wherein the sample vessel is inserted in the annular interior space of a ring magnet associated with the sample vessel holder; separating of the solution from the magnetic particles; and isolating of the nucleic acids from the solution. | 10-06-2011 |
20140186236 | METHOD FOR PURIFICATION OF NUCLEIC ACIDS, PARTICULARLY FROM FIXED TISSUE - The invention relates to a method for purification of nucleic acids, to a kit for performing the method according to the invention and to a new application of magnetic particles for purification of a biological sample. The method according to the invention comprises the following steps: a) accommodating of the sample in a first sample vessel in an aqueous solution and lysing of the sample under non-chaotropic conditions; suspending of first magnetic particles in the solution and inserting of the first sample vessel in a sample vessel holder, wherein the sample vessel is inserted in the annular interior space of a ring magnet associated with the sample vessel holder; separating of the solution from the magnetic particles; and isolating of the nucleic acids from the solution. | 07-03-2014 |
Heike Faulhammer, Saint Germain En Laye FR
Patent application number | Description | Published |
---|---|---|
20100105812 | COPOLYAMIDE, COMPOSITION CONTAINING SUCH COPOLYAMIDE AND USE THEREOF - The invention relates to a copolyamide containing at least two patterns (monomers) and of the following general formula A/(Cz diamine)·(Cw diacid) in which: z is the number of carbon atoms of the diamine and w is the number of carbon atoms of the diacid; and A is selected from a pattern obtained from an amino acid and a pattern of the general formula (Cx diamine)·(Cy diacid) | 04-29-2010 |
Heike Fischer, Meerbusch DE
Patent application number | Description | Published |
---|---|---|
20080208209 | Device for delivering a self-expanding stent in a vessel of the body - The present invention relates to a device for delivering a self-expanding stent in a vessel of the body. The device comprises a tubular sheath which, in a distal section, keeps the stent radially compressed, and a pusher element, which is guided in the tubular sheath, in order to stabilize the stent when the sheath is pulled back. A handle is also provided, with a passage via which the pusher element is secured on the handle. The device further comprises a tubular rod which is fixedly connected to the handle and inside which the pusher element is provided, and which is provided at least in part with regularly spaced elevations and with depressions lying between the elevations. In addition, a movable element is provided which is arranged movably over the rod, distally from the handle, and whose movement in the proximal direction allows the sheath to be pulled back. | 08-28-2008 |
Heike Flösser-Müller, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20090280075 | METHOD FOR INCREASING THE SUN PROTECTION FACTOR OF A COSMETIC AND/OR DERMATOLOGICAL PREPARATION - The present invention relates to a method of increasing the sun protection factor of a cosmetic and/or dermatological preparation, to the use of UV-A filters for increasing the sun protection factor of such a preparation and to specific photoprotective cosmetic and/or dermatological preparations. | 11-12-2009 |
Heike Foelster, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20090208437 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS - Glycopyrronium bromide, derivatives and/or isomers thereof in combination with one or more active substances selected from a list of substances as recited in the claims and/or in the form of a W/Si emulsion, an O/W gel, a soap gel stick, and/or a surfactant-containing cleansing formula, and corresponding cosmetic preparations, in particular deodorant/antiperspirant preparations. | 08-20-2009 |
Heike Gielen-Haertwig, Monheim DE
Patent application number | Description | Published |
---|---|---|
20080255068 | Chemical Compound and Its Use - The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis. | 10-16-2008 |
20090214675 | 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof - The present application relates to novel 4-chromenonyl-1,4-dihydropyridinecarbonitriles, processes for their preparation, pharmaceutical compositions containing them, and their use for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders. | 08-27-2009 |
20100003709 | Crystal Structure of Enzyme and Uses Thereof - This invention relates to crystallised human neutrophil elastase and the use of its three-dimensional structure to design modulators for human neutrophil elastase. | 01-07-2010 |
20100010024 | USE OF1,4-DIARYL-DIHYDROPYRIMIDINE-2-ON DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTENSION - The present application relates to the use of 1,4-diaryldihydropyrimidin-2-one derivatives of the formula (I) for the treatment and/or prophylaxis of pulmonary arterial hypertension and other types of pulmonary hypertension, and to the use thereof for the manufacture of medicaments for the treatment and/or prophylaxis of pulmonary arterial hypertension and other types of pulmonary hypertension. | 01-14-2010 |
20100022484 | 4-Chromenonyl-1,4-dihydropyridines and their use - The present application relates to novel 4-chromenonyl-1,4-dihydropyridines, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders. | 01-28-2010 |
20100022537 | I-PHENY 1-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVES AND THEIR USE - This invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development. | 01-28-2010 |
20100184788 | HETEROCYCLIC DERIVATIVES - The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development. | 07-22-2010 |
20120142728 | CHEMICAL COMPOUND AND ITS USE - The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis. | 06-07-2012 |
Heike Glowatz, Hilden DE
Patent application number | Description | Published |
---|---|---|
20100209993 | PERMANENT INACTIVATION OF NUCLEASES - The present invention relates to the use of reagent for permanently inactivating nucleases wherein the reagent comprises an oxidizing agent, a protein denaturant and optionally a pH adjustor and to a method for permanently inactivating nucleases using said reagent. | 08-19-2010 |
Heike Gregorius, Koblenz DE
Patent application number | Description | Published |
---|---|---|
20090030166 | Preparation of supported catalyst systems containing reduced amounts of aluminoxanes - The present invention relates to a process for preparing a catalyst solid for olefin polymerization, comprising a finely divided support, an aluminoxane and a metallocene compound, which comprises: a) firstly combining the finely divided support with the aluminoxane and subsequently b) adding the reaction product of a metallocene compound with at least one organometallic compound to the modified support, catalyst solids obtainable by this process, catalyst systems comprising these catalyst solids, their use for the polymerization of olefins and a process for the polymerization of olefins. | 01-29-2009 |
20090124770 | Supported Metal Alkyl Compound and Process for the Polymerization of Olefins in Its Presence - The present invention relates to pulverulent solids obtainable by reaction of a metal alkyl compound of a divalent or higher-valent metal and a finely divided support which on its surface bears functional groups which can form a chemical bond between the metal atom of the metal alkyl compound and the surface of the support, wherein the particles of the finely divided support have particle diameters of less than 1000 nm and less than 5% by weight of the metal alkyl compound is extractable in a single extraction of the pulverulent solid with 20 ml of heptane per gram of solid at 50° C. In addition, the invention relates to a process for preparing the pulverulent solids, a catalyst composition for the polymerization of olefins which comprises the pulverulent solids and polymerization processes using the catalyst composition. | 05-14-2009 |
20130267407 | METHOD OF PREPARING METALLOCENE CATALYSTS - Methods of preparing silica-supported catalysts useful for olefin polymerization are described. The catalysts comprise a metallocene complex. An activator mixture made from a boron acid compound and methylalumoxane is combined with either: (i) the metallocenecomplex, followed by calcined or chemically treated silica to give a supported catalyst; or (ii) calcined or chemically treated silica, followed by the metallocenecomplex to give a supported catalyst. The methods provide active supported catalysts. | 10-10-2013 |
Heike Grewenig, Ledbury GB
Patent application number | Description | Published |
---|---|---|
20100260919 | REDUCED FAT CHOCOLATE - The present invention provides a reduced fat chocolate composition comprising erythritol. In one embodiment the chocolate composition is characterised in that it has a total fat content of from 15 wt % to 24.9 wt %. In another embodiment the chocolate composition comprising erythritol is characterised in that it has a total fat content of from 15 wt % to 26 wt % and does not comprise inulin or fructo oligosaccharide (FOS). A process for the preparation of the chocolate composition is provided, said process having processing parameters similar to those for high fat chocolate. | 10-14-2010 |
20110014350 | CHOCOLATE COMPOSITION - The present invention provides a chocolate composition comprising erthyritol and one or more ingredients selected from maltodextrin, a high protein ingredient, maltitol and polydextrose. Erythritol may be used in place of some or all of the sucrose normally employed in a chocolate composition and thereby provide a chocolate composition having a reduced sugar and/or calorie content chocolate. A process for the preparation of the chocolate composition is also provided. | 01-20-2011 |
Heike Guder, Wiesloch DE
Patent application number | Description | Published |
---|---|---|
20100287135 | CAPTURING OLAP ANALYSIS THREAD AS REFRESHABLE BUSINESS INTELLIGENCE DATA - Described herein are methods and systems for capturing OLAP analysis thread and transferring the data into a data visualization tool. According to one aspect, OLAP analysis step queries and the corresponding results are recorded and transferred to a data visualization tool. In another aspect, the data in the data visualization tool may be refreshed without affecting the data format. | 11-11-2010 |
Heike Heckroth, Wuppertal DE
Patent application number | Description | Published |
---|---|---|
20100035900 | 6-Arylmethyl-substituted pyrazolopyrimidines - The invention relates to novel 6-arylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory. | 02-11-2010 |
20110065730 | 6-CYCLYLMETHYL-AND 6-ALKYLMETHYL-SUBSTITUTED PYRAZOLEPYRIMIDINES - The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory. | 03-17-2011 |
20120010224 | 6-CYCLYLMETHYL-AND 6-ALKYLMETHYL-SUBSTITUTED PYRAZOLEPYRIMIDINES - The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory. | 01-12-2012 |
Heike Hugenberg, Langenfeld DE
Patent application number | Description | Published |
---|---|---|
20100285965 | METHODS OF IMPROVING PLANT GROWTH - The invention relates to the use of at least one compound selected from the class of the enaminocarbonyl compounds for enhancing plants' intrinsic defenses and/or for improving plant growth and/or for enhancing the resistance of plants to plant diseases which are caused by fungi, bacteria, viruses, MLOs ( | 11-11-2010 |
Heike Huscher, Berlin DE
Patent application number | Description | Published |
---|---|---|
20100200888 | Silicon-Based Sub-Mount for an Opto-Electronic Device - A package for an optoelectronic device (e.g., a light emitting device such as a LED) includes a sub-mount including a silicon substrate having a thickness in the range of 350 μm-700 μm. The optoelectronic device is mounted on a die attach pad on the front-side surface of the substrate. Feed-through metallization in one or more via structures electrically couples the die attach pad to a contact pad on the back-side surface of the substrate. | 08-12-2010 |
Heike Idink, Esslingen DE
Patent application number | Description | Published |
---|---|---|
20090222104 | ASYMMETRIC FORMATION OF PROSTHETIC COMPONENTS FOR THE MANIPULATION AND SUPPRESSION OF NATURAL FREQUENCIES - A hip joint prosthesis for implantation in the femur of a patient, wherein the shaft can be coupled with a ball head which in turn can be inserted rotatably in the hemispherical recess of a socket insert. To avoid squeaking the shaft is formed asymmetrically in its outer and/or inner geometry and/or material composition. | 09-03-2009 |
20090259318 | ASYMMETRIC FORMATION OF SOCKETS AND/OR SOCKET INSERTS FOR THE MANIPULATION AND SUPRESSION OF NATURAL FREQUENCIES - A socket or socket insert for a hip joint prosthesis, the shaft of which can be coupled with a ball head which in turn can be inserted in a rotatable manner in the hemispherical recess of the socket insert wherein the shaft can be implanted in the femur and the socket insert can be implanted directly or via a hip socket in the pelvic bone. To avoid squeaking, the socket and/or the socket insert are asymmetrically in their inner or outer geometries. | 10-15-2009 |
Heike Ilias, Wedemark DE
Patent application number | Description | Published |
---|---|---|
20080258413 | Level Control System for a Vehicle, and Method for Operating a Level Control System for a Vehicle - A level control system for a vehicle includes a pressure generator ( | 10-23-2008 |
20080288138 | Method for Controlling the Quantity of Air in a Self-Contained Air Supply System for a Chassis - In order to simplify air flow control in a self-contained air supply system, an average control speed is calculated on the basis of a defined movement of the air springs ( | 11-20-2008 |
20110278804 | METHOD FOR CONTROLLING THE REGENERATION CYCLES FOR AN AIR DRYER IN A CLOSED RIDE CONTROL SYSTEM FOR VEHICLES - A method for controlling the regeneration cycles for an air dryer in a closed ride height control system for vehicles. Compressed air chambers and a compressed air storage reservoir are charged with compressed air and ventilated via a compressed air line, or are charged via a compressed air intake line connected to the compressor and ventilated via the compressed air line. Compressed air quantity delivered through the dryer by the compressor, and temperature and/or the humidity of the air sucked in from the atmosphere are measured. The dryer is considered saturated under the assumption that air sucked in by the compressor and delivered through the air dryer is at the highest possible ambient temperature and humidity. Regeneration air quantity required for the compressed air quantity for the dryer to attain the desired dew point is determined as a function of the ambient temperature and/or the humidity of the intake air. | 11-17-2011 |
Heike Klesper, Bergisch Gladbach DE
Patent application number | Description | Published |
---|---|---|
20100308307 | METHOD FOR PRODUCTION OF AN ORGANIC LIGHT EMITTING DIODE OR OF AN ORGANIC SOLAR CELL AND ORGANIC LIGHT EMITTING DIODES OR SOLAR CELLS PRODUCED THEREWITH - The present invention relates to an electronic device. Examples for such an electronic device are an optical detector, a laser diode, a field-quenching device, an optical amplifier, an organic solar cell or an organic light emitting diode. | 12-09-2010 |
Heike Kluson-Hesslinger, Freiberg DE
Patent application number | Description | Published |
---|---|---|
20100032356 | Fuel Filter of an Internal Combustion Engine - A fuel filter of an internal combustion engine has a filter housing with a housing base body of cast metal and at least one lid. Screws are provided for attaching the at least one lid to the housing base body. A lid seal seals the at least one lid relative to the housing base body. The housing base body has screw receptacles for the screws and a seal seat for the lid seal. The screws are self-tapping screws. The screw receptacles and the seal seat are formed by casting technology without after machining. | 02-11-2010 |
20100032360 | Fuel Filter of a Motor Vehicle - A fuel filter of a motor vehicle is designed to be mounted in a traveling direction of the motor vehicle and has a filter housing with a housing base body. The housing base body has a front side facing in the traveling direction. The front side of the housing base body has an external, integrally formed rib structure configured and adapted as impact protection. | 02-11-2010 |
20110017657 | Filter Device, Especially Liquid Filter - A filter device comprises a hollow cylindrical filter element in a filter housing. The fluid that is to be purified is to radially flow through the filter element. The interior of the filter element forms an axial flow chamber for the fluid. An end plate is arranged on the front side of the filter element. An annular neck, onto which a sealing element is injection-molded, is connected to the end plate. | 01-27-2011 |
20150014239 | Filter Device, Especially Liquid Filter - A filter device comprises a hollow cylindrical filter element in a filter housing. The fluid that is to be purified is to radially flow through the filter element. The interior of the filter element forms an axial flow chamber for the fluid. An end plate is arranged on the front side of the filter element. An annular neck, onto which a sealing element is injection-molded, is connected to the end plate. | 01-15-2015 |
Heike Kniel, Heppenheim DE
Patent application number | Description | Published |
---|---|---|
20090023749 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL)BUTYL-4-(2- -CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 01-22-2009 |
20100016332 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL) BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine, crystaline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 01-21-2010 |
20110183994 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL) BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline Modifications of the hydrochloride of 1-[4-(5-cyanoin-dol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoin-dol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2 -carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 07-28-2011 |
20110190317 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL) BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 08-04-2011 |
20110294824 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL)BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 12-01-2011 |
20110294825 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL)BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 12-01-2011 |
20110312971 | POLYMORPHIC FORMS OF 1-'4-(5-CYANOINDOL-3-YL) BUTYL-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 12-22-2011 |
20130102616 | POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL)PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 04-25-2013 |
20140024658 | POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypertension, cerebral disorders, chronic pain, acromegaly, hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 01-23-2014 |
20140275115 | POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypertension, cerebral disorders, chronic pain, acromegaly, hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 09-18-2014 |
20150080411 | POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE - The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypertension, cerebral disorders, chronic pain, acromegaly, hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation. | 03-19-2015 |
Heike Launhardt, Freiburg DE
Patent application number | Description | Published |
---|---|---|
20080201804 | Protein Production - The present invention relates to a method for producing heterologous glycosylated proteins in non-animal eukaryotic cells such as in transformed bryophyte, yeast, ciliate or algae cells. In particular, the method relates to a method for producing glycosylated proteins comprising animal glycosylation patterns—comprising sialic acid residues—, such as pharmaceutical proteins for use in mammals, e.g. humans, in bryophyte cells such as those of | 08-21-2008 |
20100050292 | Galactosyltransferase - The invention discloses DNA molecules encoding galactosyltransferases, recombinant host cells, tissues or organisms comprising dysfunctional galactosyltransferase gene(s), recombinant host cells, tissues or organisms comprising an introduced functional galactosyltransferase gene, methods for the production of proteins therewith, methods for the production of galactosyltransferase and vectors and uses thereof. | 02-25-2010 |
Heike Mertsching, Sindelfingen DE
Patent application number | Description | Published |
---|---|---|
20100015704 | PROCESS FOR THE ENRICHMENT OF MELANOCYTES BY MEANS OF MODIFIED SURFACES - The present invention relates to processes for obtaining melanocytes from a cell suspension, in particular from an epidermal cell suspension, by means of a culture vessel, wherein at least a part of the surface of the culture vessel facing the culture space, is modified, in particular functionalized, in particular by means of a low-pressure plasma process. Furthermore, the present invention relates to culture vessels which are modified, in particular functionalized, in particular by means of a low-pressure plasma process and are suitable for obtaining melanocytes and the use of such culture vessels for obtaining melanocytes. | 01-21-2010 |
20100120145 | THREE-DIMENSIONAL BIOCOMPATIBLE SKELETON STRUCTURE CONTAINING NANOPARTICLES - The invention relates to a cell culture system comprising a three-dimensional, biocompatible frame structure and biocompatible nanoparticles, a method for the cultivation of cells, and the preparation of cells or cell products and tissues per se by means of such a cell culture system. | 05-13-2010 |
20100216239 | ISOLATED NATURE-IDENTICAL COLLAGEN - The present invention concerns isolated collagen, the method for its production, and isolation of the collagen from collagen-containing tissues, as well as the use of the isolated collagen in a biomatrix as an in vitro test system, tissue replacement or organ replacement. | 08-26-2010 |
20100315628 | ARRANGEMENT AND METHOD FOR ANALYSIS OF BIOLOGICAL SAMPLES - The invention lies in the technical field of cell biology and transplantation medicine. It concerns devices and methods for rapid and noninvasive analysis or checking of biological samples, especially for sterility control, for characterization of infectious particles and microorganisms contained in the biological sample and for characterization of tissue cells and transplants. The main areas of application of the invention are biotechnological production of pharmacological active ingredients and therapeutic agents as well as transplantation medicine. | 12-16-2010 |
Heike Miertsch, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20090208437 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS - Glycopyrronium bromide, derivatives and/or isomers thereof in combination with one or more active substances selected from a list of substances as recited in the claims and/or in the form of a W/Si emulsion, an O/W gel, a soap gel stick, and/or a surfactant-containing cleansing formula, and corresponding cosmetic preparations, in particular deodorant/antiperspirant preparations. | 08-20-2009 |
20110217254 | ANTIPERSPIRANT PREPARATIONS COMPRISING HYDROTALCITE - Hydrotalcite helps prevent changes in the scent and color of an antiperspirant preparation comprising one or more antiperspirant and/or deodorant active ingredients and a maximum of 5% by weight of water, based on the total mass of the preparation. | 09-08-2011 |
20120058064 | USE OF CHARGED SURFACTANTS FOR REDUCING TEXTILE STAINING BY ANTIPERSPIRANTS - The invention comprises the use of one or more charged surfactants in preparations having an antiperspirant effect for reducing staining in or on clothing and improving improvement the ability of stains to be washed out of the clothing. | 03-08-2012 |
20140090183 | USE OF CHARGED SURFACTANTS FOR REDUCING TEXTILE STAINING BY ANTIPERSPIRANTS - Disclosed is a method of gauging stains on or in clothing which are caused at least in part by a cosmetic or dermatological preparation that comprises antiperspirant substances. The method comprises successively applying to a location of the clothing the preparation and sebum, washing and drying the clothing, and thereafter subjecting the clothing to a photometrical measurement by means of colorimetric measures in a CIE L*a*b color space and comparing the obtained value to a value obtained with an untreated area of the clothing. | 04-03-2014 |
20140093463 | USE OF CHARGED SURFACTANTS FOR REDUCING TEXTILE STAINING BY ANTIPERSPIRANTS - Disclosed is a method of reducing or avoiding staining in or on clothing caused by a cosmetic or dermatological preparation comprising one or more antiperspirant substances and/or of improving the ability of stains in or on clothing which are caused at least in part by said preparation to be washed out from the clothing. The method comprises including in the preparation one or more cationic surfactants. | 04-03-2014 |
20140093464 | USE OF CHARGED SURFACTANTS FOR REDUCING TEXTILE STAINING BY ANTIPERSPIRANTS - Disclosed is cosmetic or dermatological preparation which is present as an aerosol spray and comprises one or more antiperspirant substances and one or more cationic surfactants. | 04-03-2014 |
20140105841 | USE OF CHARGED SURFACTANTS FOR REDUCING TEXTILE STAINING BY ANTIPERSPIRANTS - Disclosed is cosmetic or dermatological preparation which comprises one or more antiperspirant substances and one or more cationic surfactants. | 04-17-2014 |
20140294976 | COSMETIC PREPARATION COMPRISING PULVERIZED HYDROPHILIC SUBSTANCES - A substance, which is in principle insoluble in a cosmetic or dermatological anhydrous preparation is converted into a powdery product by absorption onto a carrier, the powdery product being soluble in the preparation. The anhydrous preparations comprise one or more hydrophilic substances or substance mixtures which are liquid, pasty at room temperature and/or meltable up to a temperature of 150° C. and which are absorbed on one or more particulate carriers. The hydrophilic substance or substance mixture in itself is insoluble or sparingly soluble in the preparation and the carriers are characterized by a particle size ranging from 5 nm to 2 mm, a tamped density of between 50 kg/m | 10-02-2014 |
20140335188 | COSMETIC PREPARATION COMPRISING PULVERIZED HYDROPHOBIC SUBSTANCES - A substance, which is in principle insoluble in a cosmetic or dermatological preparation, is converted into a powdery product by absorption onto a carrier, wherein said powdery product can be distributed better in the preparation. The preparations comprise water and one or more hydrophobic substances or substance mixtures which are liquid and pasty at room temperature and/or meltable up to a temperature of 150° C. and which are absorbed on one or more particulate carriers. The hydrophobic substance or substance mixture in itself is insoluble or sparingly soluble in the preparation and the carriers are characterized by a particle size ranging from 5 nm to 2 mm, a tamped density of between 50 kg/m | 11-13-2014 |
Heike Petrul, Berlin DE
Patent application number | Description | Published |
---|---|---|
20090081207 | High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity - The present invention relates to recombinant human or humanized polypeptides which bind to α5β1 integrin with high affinity and blocking function. Further, diagnostic and pharmaceutic applications of the potypeptides are disclosed. | 03-26-2009 |
20090137002 | ANTI EPHB4 ANTIBODIES AND ANTIBODY FRAGMENTS - The invention concerns antibodies and antibody fragments, specifically recognising the EphB4 receptor comprising heavy chains and light chain, comprising light and heavy CDR's, and their use as medicament for the treatment of pathological angiogenesis, in particular cancer therapy. | 05-28-2009 |
20130066055 | NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF - The present application relates to new binder-drug conjugates (ADCs) of N,N-dialkylauristatins that are directed against the target C4.4a, to active metabolites of these ADCs, to processes for preparing these ADCs, to the use of these ADCs for treating and/or preventing illnesses, and also to the use of these ADCs for producing medicaments for treating and/or preventing illnesses, more particularly hyperproliferative and/or angiogenic diseases such as, for example, cancer diseases. Such treatments may be practised as a monotherapy or else in combination with other medicaments or further therapeutic measures. | 03-14-2013 |
20130122024 | NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF - The present application relates to new binder-drug conjugates (ADCs) of N,N-dialkylauristatins that are directed against the target mesothelin, to active metabolites of these ADCs, to processes for preparing these ADCs, to the use of these ADCs for treating and/or preventing illnesses, and also to the use of these ADCs for producing medicaments for treating and/or preventing illnesses, more particularly hyperproliferative and/or angiogenic diseases such as, for example, cancer diseases. Such treatments may be practised as a monotherapy or else in combination with other medicaments or further therapeutic measures. | 05-16-2013 |
20140127240 | Novel Binder-Drug Conjugates (ADCs) and Use of Same - The present patent application relates to novel binder-drug conjugates (ADCs) of N,N-dialkylauristatins directed against the target epidermal growth factor receptor (EGFR, gene ID 1956), effective metabolites of these ADCs, methods for producing these ADCs, use of these ADCs for treatment and or prevention of diseases as well as the use of these ADCs to produce pharmaceutical drugs for treatment and/or prevention of diseases, in particular hyperproliferative and/or angiogenic diseases such as cancer, for example. Such treatments may be administered as monotherapy or in combination with other pharmaceutical drugs or other therapeutic measures. | 05-08-2014 |
20150030618 | NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF - The present application relates to new binder-drug conjugates (ADCs) of N,N-dialkylauristatins that are directed against the target C4.4a, to active metabolites of these ADCs, to processes for preparing these ADCs, to the use of these ADCs for treating and/or preventing illnesses, and also to the use of these ADCs for producing medicaments for treating and/or preventing illnesses, more particularly hyperproliferative and/or angiogenic diseases such as, for example, cancer diseases. Such treatments may be practised as a monotherapy or else in combination with other medicaments or further therapeutic measures. | 01-29-2015 |
Heike Pfistner, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20090186231 | PROCESS FOR COATING PLASTIC OR METAL SURFACES - A method of coating surfaces of plastic or metal, which comprises treating the plastic or metal surface in question with an aqueous dispersion comprising | 07-23-2009 |
20100178310 | AQUEOUS FORMULATION AND PROCESS FOR THE IMPREGNATION OF NON-LIVING-MATERIALS IMPARTING A PROTECTIVE ACTIVITY AGAINST PESTS - A formulation for the impregnation of non-living-materials, preferably textile materials, comprising at least a pesticide and a polymeric binder comprising as monomers at least ethylene and an unsaturated carboxylic acid, process for impregnating such materials and the use of such impregnated materials as mosquito-nets and for the protection of plants and other goods. | 07-15-2010 |
20100266792 | COMPOSITE MATERIALS AND METHOD FOR PRODUCTION THEREOF - Composite materials comprising at least one natural fiber, at least one thermoplastic polymer, and at least one random copolymer having a molar mass M | 10-21-2010 |
20100291231 | Compositions as Wound Sealant - The present invention relates to compositions which, in sprayable or form, are suitable as wound sealants for woody plants. The invention also relates to a method of protecting woody plants from infection with phytopathogenic fungi, in particular ESCA infection, using such wound sealants. | 11-18-2010 |
20110089075 | METHOD FOR COATING GLASS, POLYETHYLENE OR POLYESTER CONTAINERS, AND SUITABLE AQUEOUS FORMULATIONS FOR SAID COATING METHOD - A method of coating containers made of glass, polyethylene or polyester by treatment with a substantially paraffin-free aqueous formulation comprising | 04-21-2011 |
20110130318 | ENZYME COMPOSITION COMPRISING ENZYME CONTAINING POLYMER PARTICLES - The present invention relates to an enzyme composition comprising enzyme containing polymer particles, which is useful for detergent compositions, in particular for liquid detergent compositions. In these enzyme containing particles, the particles comprise i) at least one enzyme, and ii) at least one polymer P, which is selected from homo- and copolymers having a backbone, wherein the C—C-backbone carries carboxylgroups, which may be present in the acidic form or in the neutralized form, and wherein the C—C-backbone comprises hydrophobic repeating units. | 06-02-2011 |
20110184129 | METHOD FOR PRODUCING ETHYLENE COPOLYMERS - Process for the continuous preparation of ethylene copolymers by free-radical copolymerization of ethylene and at least one comonomer (b) selected from among ethylenically unsaturated carboxylic acids, esters of ethylenically unsaturated carboxylic acids, ethylenically unsaturated phosphonic acids and esters of ethylenically unsaturated phosphonic acids, wherein one or more inhibitors are metered separately from ethylene and the comonomer or comonomers (b) into the reaction mixture. | 07-28-2011 |
20110253010 | PE WAX DISPERSIONS IN THE COATING OF PLASTICS - An aqueous paint formulation composed of an aqueous basecoat and an aqueous dispersion of an at least partially neutralized ethylene copolymer wax which is selected from ethylene copolymer waxes comprising as comonomers in copolymerized form: | 10-20-2011 |
20120130001 | MODIFIED CELLULOSE FIBERS, PRODUCTION AND USE THEREOF - A method for producing composite materials which comprises in one step preparing modified cellulose fibers by treating | 05-24-2012 |
20120231284 | PROCESS FOR COATING PLASTIC OR METAL SURFACES - A method of coating surfaces of plastic or metal, which comprises treating the plastic or metal surface in question with an aqueous dispersion comprising | 09-13-2012 |
20140116294 | PE WAX DISPERSIONS IN THE COATING OF PLASTICS - An aqueous paint formulation having an aqueous basecoat and an aqueous dispersion having an at least partially neutralized ethylene copolymer wax, wherein the ethylene copolymer wax contains as comonomers in copolymerized form (A) 12-40 wt % of an ethylenically unsaturated carboxylic acid of formula (I), (B) 60-88 wt % of ethylene, and (C) 0-10 wt % of a further comonomer; or the ethylene copolymer was contains as comonomers in copolymerized form (A′) 5-50 wt % of a comonomer of formula (II), (B′) 50-95 wt % of ethylene, and (C′) 0-20 wt % of a further comonomer; wherein the ethylene copolymer wax comprising the comonomers (A), (B), and optionally (C) has a molecular weight M | 05-01-2014 |
Heike Prenz, Dresden DE
Patent application number | Description | Published |
---|---|---|
20090142916 | APPARATUS AND METHOD OF MANUFACTURING AN INTEGRATED CIRCUIT - On aspect is a method to manufacture an integrated circuit including a reshaping process of the wafer edge region and an apparatus to perform the reshaping process. | 06-04-2009 |
Heike Radeke, Dedham, MA US
Patent application number | Description | Published |
---|---|---|
20090258901 | LIGANDS FOR MONOAMINE RECEPTORS AND TRANSPORTERS, AND METHODS OF USE THEREOF - One aspect of the present invention relates to heterocyclic compounds. A second aspect of the present invention relates to the use of the heterocyclic compounds as ligands for various mammalian cellular receptors, including dopamine, serotonin, or norepinephrine transporters. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, schizophrenia, Parkinson's disease, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, and Tourette's syndrome. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds, and the screening of those libraries for biological activity, e.g., in assays based on dopamine transporters. | 10-15-2009 |
Heike SchÄcke, Berlin DE
Heike Schaecke, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080227820 | CYCLIC PHENYL-SUBSTITUTED INDAZOLS, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS - The present invention relates to the compounds of formula I, | 09-18-2008 |
20100144742 | MULTIPLY-SUBSTITUTED TETRAHYDRONAPHTHALENE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS - The invention relates to multiply-substituted tetrahydronaphthalene derivatives of formula (I) | 06-10-2010 |
Heike Schauerte, Munchen DE
Patent application number | Description | Published |
---|---|---|
20080275063 | Inhibitors of protein kinases - The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceutical compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. | 11-06-2008 |
20090221581 | Methods of treating pain - The invention relates to methods of treating any type of pain comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 09-03-2009 |
20100168144 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. formula (I). | 07-01-2010 |
20100184780 | INHIBITORS OF PROTEIN KINASES - The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I). | 07-22-2010 |
20100184789 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 07-22-2010 |
20110306602 | 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. | 12-15-2011 |
20130331407 | INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 12-12-2013 |
20130338147 | 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases. | 12-19-2013 |
Heike Schirmer-Ditze, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20080261852 | Bleach Reinforcer Combination for Use in Washing and Cleaning Agents - The performance of peroxide compounds, in particular when associated with bleaches for washing ink stains out of textiles, can be improved by a composition comprising: (i) a peroxygen-containing bleaching agent, (ii) a bleach activator selected from the group consisting of amide bleach activators, sulfonyl phenyl ester bleach activators, quaternary nitrogen substituted acetonitrile bleach activators, and mixtures thereof, and (iii) a compound selected from the group consisting of ligands corresponding to the general formula (I), bleach catalysts corresponding to the general formula (II), and mixtures thereof: | 10-23-2008 |
20100180388 | Ironing Pad Comprising a Solid Stain Treatment Composition - The invention relates to an ironing pad comprising a cover and a solid stain treatment composition. The solid stain treatment composition is produced from a solid material reversibly solidifying a fluid and a fluid stain treatment agent. The invention relates to a method for treating a stain on a textile fabric having such an ironing pad, the ironing pad being placed on the stain, and heat and/or pressure being applied to the ironing pad. | 07-22-2010 |
20100186268 | Ironing Pad Comprising Liquid Stain Treatment Agent - The invention relates to an ironing pad comprising a solid material ( | 07-29-2010 |
Heike Schirmer-Ditze, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20090183317 | Detergent or Treatment Agent Portion - A dimensionally stable, single-piece detergent or treatment agent portion having a weight of at least 50 g, having a system for controlling the solubility of the detergent or treatment agent. In washing, treating, or rinsing cycles of a washing machine for textiles, a maximum 50 wt % of the detergent or treatment agent portion dissolves or disperses in municipal water (16° d) at a maximum temperature of 20° C. as dissolves or disperses in municipal water (16° d) at a temperature of 50° C., enabling targeted release of the active substances in the portion during the cycles of a washing or treating program using heated water. | 07-23-2009 |
20090192069 | Washing or Cleaning Composition with Size-Optimized Active Bleaching Ingredient Particles - A bleaching agent, as well as a bleach-intensifying transition metal complex compound, incorporated in shelf-stable fashion into agents made up of multiple powder components. A solid washing detergent or cleaning agent containing particulate alkali percarbonate having an average particle size in the range from 1.0 to 2.0 mm, and particles that contain a bleach-intensifying transition metal complex compound, having an average particle size in the range from 0.8 mm to 1.6 mm. | 07-30-2009 |
Heike Schluckwerder, Salmendingen DE
Patent application number | Description | Published |
---|---|---|
20110100684 | METHOD FOR MANUFACTURING AN ELECTRICAL CONDUCTOR BY APPLYING AT LEAST ONE PASTE, IN PARTICULAR A THICK-FILM PASTE - A method for manufacturing an electrical conductor by applying at least one paste, in particular a thick-film paste, to a substrate by a dispensing operation, wherein the paste is applied in at least one strand. | 05-05-2011 |
Heike Schluckwerder, Stuttgart DE
Patent application number | Description | Published |
---|---|---|
20090169900 | Ceramic Resistor Element or Sensor Element - A ceramic resistor element or sensor element includes a ceramic substrate, which is exposable to a gas atmosphere containing carbon compounds, the ceramic substrate being provided with a coating. The coating includes copper, cerium and/or vanadium. | 07-02-2009 |
Heike Schmidt, Obersulm DE
Patent application number | Description | Published |
---|---|---|
20100059240 | METHOD FOR TIGHTENING A SCREW CONNECTION AND SCREW DRIVING TOOL - Disclosed is a method for screwing in and tightening a screw connection ( | 03-11-2010 |
Heike SchÖne, Elsvra DE
Patent application number | Description | Published |
---|---|---|
20100126891 | PACKAGING DEVICE AND PACKAGING SYSTEM FOR ESSENTIALLY FLAT OBJECTS, FOR EXAMPLE LITHIUM-ION CELLS - Packaging device ( | 05-27-2010 |
Heike Schuchmann, Stutensee DE
Patent application number | Description | Published |
---|---|---|
20080220071 | Aqueous Suspensions of Poorly Water-Soluble and Water-Insoluble Active Ingredients and Drying Powder Produced Therefrom - Aqueous suspensions comprising: (a) at least one sparingly water-soluble or water-insoluble active agent in the form of nanoparticulate particles; (b) at least one whey component selected from the group consisting of whey proteins, whey protein hydrolysates, and mixtures thereof; and (c) at least one sucrose fatty acid ester having an HLB value of 10 to 18; processes for preparing such aqueous suspensions; powders and oil-miscible compositions prepared therefrom and uses therefore. | 09-11-2008 |
20100324211 | METHOD FOR THE HIGH-PRESSURE DISPERSION OF REACTIVE MONOMERS - The object of the invention is a method for the dispersion of reactive monomers, wherein a monomer emulsion ( | 12-23-2010 |
20120063992 | PROCESS FOR THE PRODUCTION OF NANOPARTICLES USING MINIEMULSIONS - The present invention relates to a process for the production of nanoparticles or nanostructured particles with the help of a 2-emulsion method, particles being produced through targeted coalescence of miniemulsions in a high-pressure homogenized. | 03-15-2012 |
Heike Sederoff, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20080280358 | Synthetic Peptides that Cause F-Actin Bundling and Block Actin Depolymerization - Synthetic peptides derived from sucrose synthase, and having homology to actin and actin-related proteins, sharing a common motif, useful for causing acting bundling and preventing actin depolymerization. Peptides exhibiting the common motif are described, as well as specific synthetic peptides which caused bundled actin and inhibit actin depolymerization. These peptides can be useful for treating a subject suffering from a disease characterized by cells having neoplastic growth, for anti-cancer therapeutics, delivered to subjects solely, or concomitantly or sequentially with other known cancer therapeutics. These peptides can also be used for stabilizing microfilaments in living cells and inhibiting growth of cells. | 11-13-2008 |
Heike Smula, Heidenheim DE
Patent application number | Description | Published |
---|---|---|
20100192800 | BOGIE FOR A RAIL VEHICLE WHICH HAS A DRIVE - The invention relates to a bogie for a locomotive | 08-05-2010 |
Heike Suthaus, Walzbachtal-Joehlingen DE
Patent application number | Description | Published |
---|---|---|
20080201182 | Method for determining an aggregated forecast deviation - In the method for determining an aggregated forecast deviation, deviations are aggregated in a predefined environment at all reference points in time and are incorporated into an error determination. Using this method, the aggregated forecast deviation for a product is determinable so that this product may be made available in a sufficient quantity. The method is thus suitable, e.g., for disposition planning, warehouse management, or warehousing products of all types. | 08-21-2008 |
Heike Wagner, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20090306024 | Combination preparations of o-acetylsalicylic acid salts - The present invention relates to a fixed combination comprising a salt of o-acetylsalicylic acid with a basic amino acid as component A and an HMG-CoA reductase inhibitor as component B, a medicament comprising this combination and a process for its production. | 12-10-2009 |
Heike Wessendorf, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090023131 | CIRCUIT ARRANGEMENT FOR INJECTING NUCLEIC ACIDS AND OTHER BIOLOGICALLY ACTIVE MOLECULES INTO THE NUCLEUS OF HIGHER EUCARYONTIC CELLS USING ELECTRICAL CURRENT - The invention relates to a novel circuit arrangement for electrotransfection or electrofusion, which enables the transportation of DNA and/or other biologically active molecules to the nucleus of higher eukaryotic cells or the fusion of cells, independent of cell division and with reduced cell mortality. | 01-22-2009 |
20110117654 | BUFFER SOLUTION FOR ELECTROPORATION AND A METHOD COMPRISING THE USE OF THE SAME - A method for introducing biologically active molecules into animal or human cells using an electric current includes suspending the cells and dissolving the biologically active molecules in a buffer solution including HEPES and at least 10 mmol×1 | 05-19-2011 |
Heike Williams, Schwabenheim DE
Patent application number | Description | Published |
---|---|---|
20100179205 | Composition for Enhanced Antiparasitic Activity - The invention relates to antiparasitic compositions comprising a combination of atipamezole or its pharmaceutically acceptable salt and amitraz and their use in a method to control ectoparasite infestations on animals. | 07-15-2010 |
20110059988 | ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS - This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenylisoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method. | 03-10-2011 |
20130274302 | TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL - This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising glycofurol and an improved method for controlling, and preventing parasite infestation in animals. | 10-17-2013 |
20130281501 | TOPICAL LOCALIZED ISOXAZOLINE FORMULATION - This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals. | 10-24-2013 |
Heike Ziebarth, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080220418 | Method For Providing Dna Fragments Derived From An Archived Sample - Aspects of the present invention relate to compositions and methods for providing DNA fragments from an archived sample (e.g., paraffin-embedded and/or fixed-tissue biopsies, etc). Particular aspects provide methods whereby high yields of DNA are isolated as well as a substantial portion of the DNA consists of long DNA fragments, and where the isolated genomic DNA is free of associated or cross-linked contaminants like proteins, peptides, amino acids or RNA. The methods are facile, cost-effective, an are characterized by high reproducibility and reliability. Particular aspects provide methods for providing DNA fragments derived from an archived sample, wherein the yield of DNA before, for example, an amplification step is at least 20%, and amplicons up to a length of about 1,000 base pairs are amplifiable. | 09-11-2008 |
20140087449 | Method for Providing DNA Fragments Derived from an Archived Sample - Aspects of the present invention relate to compositions and methods for providing DNA fragments from an archived sample (e.g., paraffin-embedded and/or fixed-tissue biopsies, etc.). Particular aspects provide methods whereby high yields of DNA are isolated as well as a substantial portion of the DNA consists of long DNA fragments, and where the isolated genomic DNA is free of associated or cross-linked contaminants like proteins, peptides, amino acids or RNA. The methods are facile, cost-effective, and are characterized by high reproducibility and reliability. Particular aspects provide methods for providing DNA fragments derived from an archived sample, wherein the yield of DNA before, for example, an amplification step is at least 20%, and amplicons up to a length of about 1,000 base pairs are amplifiable. | 03-27-2014 |